Golden: agree, and also another point that people aren’t talking about much here that caught my ear was when Nader mentioned that a significant amount of the money they have raised is going towards ramping up the manufacturing of Leronlimab (in anticipation of FDA approval I assume). This would seem to point towards their confidence that there will be a demand for patient-ready product in the near future. It will be an interesting 1Q.
News 
Market Data 
Discover 
